Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Inventory: 2024-2025

Historic Inventory for Zevra Therapeutics (ZVRA) over the last 1 years, with Sep 2025 value amounting to $1.4 million.

  • Zevra Therapeutics' Inventory was N/A to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Zevra Therapeutics' Inventory is $1.4 million, which was up 23.38% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Zevra Therapeutics' Inventory peaked at $2.6 million during Q1 2025, and registered a low of $1.1 million during Q2 2025.
  • Over the past 2 years, Zevra Therapeutics' median Inventory value was $1.7 million (recorded in 2024), while the average stood at $1.8 million.